|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/30/22 Cryo Cell International Inc. 25 8/30/22 1:16K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 25 Notice by an Issuer of the Removal from Listing HTML 15K
and Registration on a Securities Exchange of
Matured, Redeemed or Retired Securities
| 25 |
| OMB APPROVAL |
| |||||
| OMB Number: | 3235-0080 | |||||
| Expires: | May 31, 2024 | |||||
| Estimated average burden | ||||||
| hours per response | 1.00 | |||||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING
AND/OR REGISTRATION UNDER SECTION 12(b)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-40767
Cryo-Cell International, Inc.
The Nasdaq Stock Market LLC
(Exact name of lssuer as specified in its charter, and name of Exchange
where security is listed and/or registered)
700 Brooker Creek Blvd., Suite 1800, Oldsmar, FL 34677 (813) 749-2100
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
Common Stock
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
| ☐ | 17 CFR 240.12d2-2(a)(1) |
| ☐ | 17 CFR 240.12d2-2(a)(2) |
| ☐ | 17 CFR 240.12d2-2(a)(3) |
| ☐ | 17 CFR 240.12d2-2(a)(4) |
| ☐ | Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. |
| ☒ | Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange. |
Pursuant to the requirements of the Securities Exchange Act of 1934, Cryo-Cell International, Inc. (Name of lssuer or Exchange) certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
| By | Jill Taymans |
VP Finance, CFO | ||||||||
| Date | Name | Title |
| 1 | Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions. |
| SEC 1654 (03-06) | Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
| This ‘25’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 5/31/24 | ||||
| Filed as of / Effective on: | 8/30/22 | |||
| Filed on: | 8/29/22 | 4, 8-A12B, CERT | ||
| List all Filings | ||||